Nationwide Fund Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-141,216
| Closed | -$12M | – | 1147 |
|
|
2017
Q3 | $12M | Buy |
141,216
+106,667
| +309% | +$9.06M | 0.05% | 544 |
|
|
2017
Q2 | $2.62M | Buy |
34,549
+5,881
| +21% | +$445K | 0.01% | 1313 |
|
|
2017
Q1 | $1.89M | Sell |
28,668
-66,159
| -70% | -$4.37M | 0.01% | 1421 |
|
|
2016
Q4 | $6.01M | Sell |
94,827
-23,676
| -20% | -$1.5M | 0.03% | 896 |
|
|
2016
Q3 | $7.55M | Buy |
118,503
+33,070
| +39% | +$2.11M | 0.03% | 768 |
|
|
2016
Q2 | $6.36M | Buy |
85,433
+1,171
| +1% | +$87.1K | 0.03% | 829 |
|
|
2016
Q1 | $5.65M | Buy |
84,262
+32,519
| +63% | +$2.18M | 0.02% | 870 |
|
|
2015
Q4 | $3.5M | Buy |
51,743
+33,494
| +184% | +$2.27M | 0.02% | 1111 |
|
|
2015
Q3 | $975K | Hold |
18,249
| – | – | ﹤0.01% | 1739 |
|
|
2015
Q2 | $1.15M | Sell |
18,249
-4,831
| -21% | -$304K | ﹤0.01% | 1772 |
|
|
2015
Q1 | $1.11M | Sell |
23,080
-919
| -4% | -$44.2K | ﹤0.01% | 1837 |
|
|
2014
Q4 | $797K | Sell |
23,999
-1,524
| -6% | -$50.6K | ﹤0.01% | 1926 |
|
|
2014
Q3 | $748K | Buy |
25,523
+32
| +0.1% | +$938 | ﹤0.01% | 1973 |
|
|
2014
Q2 | $991K | Buy |
25,491
+3,448
| +16% | +$134K | ﹤0.01% | 1869 |
|
|
2014
Q1 | $925K | Sell |
22,043
-43
| -0.2% | -$1.8K | ﹤0.01% | 1766 |
|
|
2013
Q4 | $725K | Sell |
22,086
-665
| -3% | -$21.8K | ﹤0.01% | 2049 |
|
|
2013
Q3 | $614K | Buy |
22,751
+1,296
| +6% | +$35K | ﹤0.01% | 2116 |
|
|
2013
Q2 | $501K | Buy |
+21,455
| New | +$501K | ﹤0.01% | 2016 |
|